Skip to end of metadata
Go to start of metadata



1a. Project Name

Clinician Guided Self-measured Blood Pressure FHIR IG

1b. Project ID

1568

1c. Is Your Project an Investigative Project (aka PSS-Lite)?

No

1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?

No

1e. Today's Date

1f. Name of standard being reaffirmed

1g. Project Artifact Information

1h. ISO/IEC Standard to Adopt

1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?

1j. Unit of Measure

2a. Primary/Sponsor WG

Patient Administration

2b. Co-Sponsor WG

Imaging Integration

2c. Co-Sponsor Level of Involvement

Request formal content review prior to ballot

2c. Co-Sponsor Involvement

2c. Co-Sponsor Update Periods

2b. Co-Sponsor WG 2

Payer/Provider Information Exchange

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 2 Update Periods

2b. Co-Sponsor WG 3

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 3 Update Periods

2b. Co-Sponsor WG 4

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 4 Update Periods

2b. Co-Sponsor WG 5

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 5 Update Periods

2b. Co-Sponsor WG 6

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 6 Update Periods

2b. Co-Sponsor WG 7

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 7 Update Periods

2b. Co-Sponsor WG 8

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 8 Update Periods

2b. Co-Sponsor WG 9

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 9 Update Periods

2b. Co-Sponsor WG 10

2c. Co-Sponsor Level of Involvement

2c. Co-Sponsor Involvement

2c. Co-Sponsor 10 Update Periods

2d. Project Facilitator

Corey Smith? Others

2e. Other Interested Parties (and roles)

2f. Modeling Facilitator

2g. Publishing Facilitator

2h. Vocabulary Facilitator

Rob Hausam?

2i. Domain Expert Representative

2j. Business Requirements Analyst

2k. Conformance Facilitator

TBD

2l. Other Facilitators

2m. Implementers

3a. Project Scope

Develop a FHIR Implementation Guide to represent Self-measured Blood Pressure Using A Remote Monitoring Device (SMBP). Goals are to:
Meet clinical criteria and gain widespread adoption in support of AMA IHMI mission
Reduce variability in the expression of meaning
Ability to compute logical subsumption and equivalence across terminology and information models (experimental)
Leverage existing tools, team strengths, and work within internally established AMA timelines

This scope focuses on clinician guided remote monitoring programs not consumer initiated monitoring

Attachments

3b. Project Need

Why Hypertension?
Uncontrolled Blood Pressure
About 85 million adults (approximately 1 in 3) in the United States have high blood pressure, a contributing factor to major health conditions including heart attack, heart failure, stroke, and kidney failure. Research also shows that in 45.9% of those with high blood pressure the condition is not controlled—36.7 million people!
Costs Beyond Patient Health
It is estimated that high blood pressure costs the country $48.6 billion each year, including health care services, medications, and missed days of work.
There are new opportunities to use remote monitoring outside the clinic.

Improving Health Outcomes: Target BP Program
Helps health care organizations, at no cost, improve BP control rates through an evidence-based quality improvement program and recognizes organizations committed to improving BP control
MEASURE blood pressure accurately, every time
Enable Patient Self‑Measurement
Patients can take an active role in their treatment by monitoring their own BP readings outside of the clinical setting.
SMBP can also help providers better diagnose high BP and effectively manage patients.
www.targetbp.com

3c. Security Risk

No

3d. External Drivers

3e. Objectives/Deliverables and Target Dates

3f. Common Names / Keywords / Aliases:

SMBP

3g. Lineage

3h. Project Dependencies

3i. HL7-Managed Project Document Repository URL:

3j. Backwards Compatibility

No

3k. Additional Backwards Compatibility Information (if applicable)

3l. Using Current V3 Data Types?

N/A

3l. Reason for not using current V3 data types?

3m. External Vocabularies

Yes

3n. List of Vocabularies

3o. Earliest prior release and/or version to which the compatibility applies

4a. Products

FHIR Extensions, FHIR Implementation Guide, FHIR Profiles

4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?

4c. FHIR Profiles Version

4d. Please define your New Product Definition

4d. Please define your New Product Family

5a. Project Intent

Create new standard, Implementation Guide (IG) will be created/modified

5a. White Paper Type

5a. Is the project adopting/endorsing an externally developed IG?

No

5a. Externally developed IG is to be (select one)

5a. Specify external organization

American Medical Association

5a. Revising Current Standard Info

5b. Project Ballot Type

STU to Normative

5c. Additional Ballot Info

5d. Joint Copyright

5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.

no

6a. External Project Collaboration

6b. Content Already Developed

60% ? 80%?

6c. Content externally developed?

Yes

6d. List Developers of Externally Developed Content

American Medical Association

6e. Is this a hosted (externally funded) project?

6f. Stakeholders

Clinical and Public Health Laboratories, Quality Reporting Agencies, Regulatory Agency, Standards Development Organizations (SDOs), Payors

6f. Other Stakeholders

6g. Vendors

Equipment, Health Care IT

6g. Other Vendors

6h. Providers

Healthcare Institutions (hospitals, long term care, home care, mental health)

6h. Other Providers

6i. Realm

Universal

7a. Management Group(s) to Review PSS

7b. Sponsoring WG Approval Date

7c. Co-Sponsor Approval Date

7c. Co-Sponsor 2 Approval Date

7c. Co-Sponsor 3 Approval Date

7c. Co-Sponsor 4 Approval Date

7c. Co-Sponsor 5 Approval Date

7c. Co-Sponsor 6 Approval Date

7c. Co-Sponsor 7 Approval Date

7c. Co-Sponsor 8 Approval Date

7c. Co-Sponsor 9 Approval Date

7c. Co-Sponsor 10 Approval Date

7d. US Realm Approval Date

7e. CDA MG Approval Date

7f. FMG Approval Date

7g. V2 MG Approval Date

7h. Architecture Review Board Approval Date

7i. Steering Division Approval Date

7j. TSC Approval Date